跳至主要内容
临床试验/NCT05103319
NCT05103319已完成不适用

Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions - A Retrospective Analysis

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 319 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
319
试验地点
1
主要终点
Pain reduction over time (long lasting)

研究概览

简要总结

This study is to retrospective investigate the effects of the simultaneous intravenous (i.v.) administration of lidocaine and ketamine on a four to six weeks interval in treatment refractory different chronic pain conditions.

详细描述

The use of intravenous infusion therapy with lidocaine or ketamine has been of interest in several chronic pain conditions. Studies showed a benefit in immediate pain reduction and even longer lasting pain relief for treatment approaches with lidocaine and ketamine.

While there is a broad database on the use of lidocaine and ketamine in chronic pain management as separate agents, very few pre-clinical animal studies have investigated the combined use of said analgesics and none of them reports their combined use in chronic pain patients.

This study is to retrospective investigate the effects of the simultaneous i.v. administration of lidocaine and ketamine on a four to six weeks interval in treatment refractory different chronic pain conditions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICD11 Medical diagnosis of chronic pain and its subcategories
  • Treatment with intravenous lidocaine and ketamine infusions during the years of 2012 to May 2021 at our pain unit at the USB
  • Patient is at least 18 years of age at the beginning of the first infusion treatment

排除标准

  • Patient is underage at the beginning of the first infusion treatment
  • Documented written refusal of consent for research (general consent or specific study consent)
  • Patients undergoing treatment with only lidocaine or ketamine respective

结局指标

主要结局

Pain reduction over time (long lasting)

时间窗: up to 1 year

The primary outcome (pain reduction over time) is explorative and not comparative, therefore no hypothesis is formulated and only descriptive/explorative statistics will be applied. Pain reduction will be analysed descriptively. Categories: any pain reduction/ pain reduction \>=50%/ pain free/ increase in pain (recorded as "no time stated/ \< 2 weeks/ ≥2 weeks/full time in-between infusions"

次要结局

  • Change in Pain (acute reduction)(up to 1 day)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验